Boston Scientific Corp (BSX) stock
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3050% below fair value
$44.20−0.93 (-2.06%)
Close on Nov 12, 2026Market cap $64.06BP/E 18.7Yield –
Boston Scientific operating margin
Operating margin is operating income as a percentage of revenue.
Boston Scientific's operating margin for the twelve months ending Sep 30, 2026 was 18.7%. For fiscal 2025 it was 18.0%, against 15.5% the year before. The highest annual figure on record is 18.0% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18.0% | +2.5 |
| FY2024 | Dec 31, 2024 | 15.5% | −0.9 |
| FY2023 | Dec 31, 2023 | 16.5% | +3.5 |
| FY2022 | Dec 31, 2022 | 13.0% | +2.9 |
| FY2021 | Dec 31, 2021 | 10.1% | +10.9 |
| FY2020 | Dec 31, 2020 | -0.8% | −14.9 |
| FY2019 | Dec 31, 2019 | 14.1% | −1.2 |
| FY2018 | Dec 31, 2018 | 15.3% | +1.1 |
| FY2017 | Dec 31, 2017 | 14.2% | +8.9 |
| FY2016 | Dec 31, 2016 | 5.3% | +9.1 |
| FY2015 | Dec 31, 2015 | -3.8% | +0.2 |
| FY2014 | Dec 31, 2014 | -4.0% | −5.7 |
| FY2013 | Dec 31, 2013 | 1.7% | +57.3 |
| FY2012 | Dec 31, 2012 | -55.6% | −67.5 |
| FY2011 | Dec 31, 2011 | 11.9% | +20.3 |
| FY2010 | Dec 31, 2010 | -8.4% | +2.5 |
| FY2009 | Dec 31, 2009 | -10.9% | +7.8 |
| FY2008 | Dec 31, 2008 | -18.7% | −18.5 |
| FY2007 | Dec 31, 2007 | -0.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 16.1% | −4.6 |
| Q2 FY2026 | Jun 30, 2026 | 21.6% | +5.5 |
| Q1 FY2026 | Mar 31, 2026 | 21.2% | +1.4 |
| Q4 FY2025 | Dec 31, 2025 | 15.6% | +0.8 |
| Q3 FY2025 | Sep 30, 2025 | 20.7% | +3.3 |
| Q2 FY2025 | Jun 30, 2025 | 16.2% | +3.6 |
| Q1 FY2025 | Mar 31, 2025 | 19.8% | +2.2 |
| Q4 FY2024 | Dec 31, 2024 | 14.8% | −0.9 |
| Q3 FY2024 | Sep 30, 2024 | 17.4% | −2.2 |
| Q2 FY2024 | Jun 30, 2024 | 12.6% | −1.7 |
| Q1 FY2024 | Mar 31, 2024 | 17.5% | +1.2 |
| Q4 FY2023 | Dec 31, 2023 | 15.7% | +3.3 |
| Q3 FY2023 | Sep 30, 2023 | 19.6% | +8.4 |
| Q2 FY2023 | Jun 30, 2023 | 14.3% | +1.2 |
| Q1 FY2023 | Mar 31, 2023 | 16.3% | +0.9 |
| Q4 FY2022 | Dec 31, 2022 | 12.4% | +6.6 |
| Q3 FY2022 | Sep 30, 2022 | 11.3% | −1.9 |
| Q2 FY2022 | Jun 30, 2022 | 13.0% | +4.5 |
| Q1 FY2022 | Mar 31, 2022 | 15.4% | +2.0 |
| Q4 FY2021 | Dec 31, 2021 | 5.8% | +3.9 |
| Q3 FY2021 | Sep 30, 2021 | 13.2% | +20.9 |
| Q2 FY2021 | Jun 30, 2021 | 8.5% | +12.1 |
| Q1 FY2021 | Mar 31, 2021 | 13.4% | +7.7 |
| Q4 FY2020 | Dec 31, 2020 | 1.8% | −5.4 |
| Q3 FY2020 | Sep 30, 2020 | -7.7% | −21.9 |
| Q2 FY2020 | Jun 30, 2020 | -3.5% | −18.1 |
| Q1 FY2020 | Mar 31, 2020 | 5.7% | −16.0 |
| Q4 FY2019 | Dec 31, 2019 | 7.2% | −5.2 |
| Q3 FY2019 | Sep 30, 2019 | 14.1% | −2.1 |
| Q2 FY2019 | Jun 30, 2019 | 14.6% | −1.1 |
| Q1 FY2019 | Mar 31, 2019 | 21.7% | +4.6 |
| Q4 FY2018 | Dec 31, 2018 | 12.5% | −0.7 |
| Q3 FY2018 | Sep 30, 2018 | 16.2% | −0.8 |
| Q2 FY2018 | Jun 30, 2018 | 15.7% | +5.8 |
| Q1 FY2018 | Mar 31, 2018 | 17.1% | +0.3 |
| Q4 FY2017 | Dec 31, 2017 | 13.2% | +6.7 |
| Q3 FY2017 | Sep 30, 2017 | 17.0% | – |
| Q2 FY2017 | Jun 30, 2017 | 10.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 16.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 6.5% | – |
See a number that looks wrong?